Figure 6
Figure 6. Calcineurin-NFAT activation is suppressed in human trisomy 21 fetal liver megakaryocytes. (A) Megakaryocyte growth in liquid culture shown as fold change of CD41+ cells (n = 5 euploid (wild-type [WT]) and 5 trisomy 21 [T21]). Results are shown as mean ± SEM. (B) Quantitative polymerase chain reaction analysis of DSCR1 mRNA in euploid (WT) and T21 fetal liver megakaryocytes relative to cyclophilin; P = .035 (n = 5 WT and 5 T21). (C) Western blot indicates increased expression of DSCR1 and phosphorylated NFATc2 (p-NFATc2) in T21 fetal liver megakaryocytes compared with control. (D) Control and T21 fetal liver megakaryocytes were immunostained for NFATc2 (red) and Hoechst (blue) before and after ionophore treatment. Arrows denote megakaryocytes.

Calcineurin-NFAT activation is suppressed in human trisomy 21 fetal liver megakaryocytes. (A) Megakaryocyte growth in liquid culture shown as fold change of CD41+ cells (n = 5 euploid (wild-type [WT]) and 5 trisomy 21 [T21]). Results are shown as mean ± SEM. (B) Quantitative polymerase chain reaction analysis of DSCR1 mRNA in euploid (WT) and T21 fetal liver megakaryocytes relative to cyclophilin; P = .035 (n = 5 WT and 5 T21). (C) Western blot indicates increased expression of DSCR1 and phosphorylated NFATc2 (p-NFATc2) in T21 fetal liver megakaryocytes compared with control. (D) Control and T21 fetal liver megakaryocytes were immunostained for NFATc2 (red) and Hoechst (blue) before and after ionophore treatment. Arrows denote megakaryocytes.

Close Modal

or Create an Account

Close Modal
Close Modal